DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of $0.47 per share for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm's quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.51 earnings per share. On average, analysts expect DENTSPLY SIRONA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
DENTSPLY SIRONA Stock Down 1.0 %
Shares of NASDAQ:XRAY traded down $0.24 during mid-day trading on Thursday, reaching $23.17. 3,464,919 shares of the stock were exchanged, compared to its average volume of 2,960,800. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The company has a market cap of $4.70 billion, a P/E ratio of -26.94, a P/E/G ratio of 1.12 and a beta of 1.00. DENTSPLY SIRONA has a one year low of $22.85 and a one year high of $37.60. The stock's 50 day simple moving average is $25.14 and its 200-day simple moving average is $26.29.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the company. Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating for the company in a research report on Thursday, July 18th. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research report on Friday, October 25th. Evercore ISI cut their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research report on Tuesday, October 8th. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research report on Monday, July 22nd. Finally, StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Monday. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $32.67.
Read Our Latest Stock Analysis on DENTSPLY SIRONA
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.